A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.

doi:10.1093/jac/39.suppl_1.53

Back to search

Article

A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.

The Journal of antimicrobial chemotherapy - 1 May 1997

Low D E, Nadler H L

Abstract excerpt

Methicillin-resistant Staphylococcus aureus (MRSA) presently represents approximately 30% of clinical isolates of S. aureus in the USA. Many strains are additionally resistant to erythromycin, 15- and 16-membered macrolides (e.g. azithromycin, spiramycin), clindamycin, aminoglycosides and/or quin...

Topics

Anti-Bacterial Agents
Colony Count, Microbial
Methicillin Resistance
Microbial Sensitivity Tests
Phenotype
Staphylococcus aureus
Virginiamycin

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.